149 results
Page 4 of 8
10-K
EX-10.53
t43xy
12 Feb 18
Annual report
12:00am
10-K
EX-10.54
nv7ge
12 Feb 18
Annual report
12:00am
10-K
EX-10.55
lcc1ngi7lpo
12 Feb 18
Annual report
12:00am
10-K
EX-10.21
0f2vz7anzj0ss86v8qh
12 Feb 18
Annual report
12:00am
10-K
EX-10.31
04t0i0fgpicjv 99hz6i
12 Feb 18
Annual report
12:00am
10-K
EX-10.52
m1tux02mjmj
12 Feb 18
Annual report
12:00am
10-K
EX-10.58
n4e4f
12 Feb 18
Annual report
12:00am
10-K
EX-10.37
h3juhq7
12 Feb 18
Annual report
12:00am
10-K
EX-10.23
b94vzwb
12 Feb 18
Annual report
12:00am
10-K
EX-10.39
b9yn88u1nro
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
9adaitl9
12 Feb 18
Annual report
12:00am
10-K
EX-10.56
15psak
12 Feb 18
Annual report
12:00am
10-K
EX-10.61
9u5n 09qqz
12 Feb 18
Annual report
12:00am
10-K
EX-10.51
4ufnal7
12 Feb 18
Annual report
12:00am
10-K
EX-10.65
97zuq
12 Feb 18
Annual report
12:00am
6-K
EX-99.1
fhl357cyk19b
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
424B5
y897l32nd5zyisxo
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
6d6d2dx7a40
30 Nov 15
Prospectus supplement for primary offering
12:00am